SCHEMBL2579239

SCHEMBL2579239

COc1ccc(C(O)c2c(C)cccc2OCc2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.49
MAPT P10636 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MAPK1 P28482 1/20 0.47
HTR1A P08908 6/20 0.46
ADRA1D P25100 5/20 0.46
ADRA1A P35348 5/20 0.46
ADRA1B P35368 5/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
DRD2 P14416 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
SGMS2 Q8NHU3 1/20 0.44
MAOB P27338 1/20 0.43
ATM Q13315 1/20 0.43
RXRA P19793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2576272 0.90 ABCB1 (0.51) ABCB1MAPTTDP1L3MBTL1MAPK1
SCHEMBL2579090 0.86 ABCB1 (0.48) ABCB1MAPTTDP1L3MBTL1MAPK1
SCHEMBL2579097 0.80 CYP1A2 (0.46) ABCB1MAPTHTR1AADRA1DADRA1A
SCHEMBL2576276 0.77 LMNA (0.52) ABCB1MAPTHTR1ACYP1A2CYP2D6
SCHEMBL5266803 0.77 LMNA (0.46) ABCB1MAPTHTR1ACYP1A2CYP2D6
SCHEMBL8064458 0.76 ABCB1 (0.53) ABCB1HTR1AADRA1DADRA1AADRA1B
SCHEMBL5381397 0.76 CYP1A2 (0.45) MAPTL3MBTL1MAPK1CYP1A2CYP2D6
SCHEMBL2580792 0.76 FFAR1 (0.48) ABCB1MAPTHTR1ACYP1A2CYP2D6
SCHEMBL6377134 0.76 CYP1A2 (0.46) ABCB1MAPTMAPK1CYP1A2CYP2D6
SCHEMBL2572231 0.76 FFAR1 (0.48) ABCB1MAPTHTR1ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048897-B2 Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2011-11-01 US disclosed
US-20080318874-A1 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-12-25 US disclosed
EP-1783110-A1 NOVEL CYCLOHEXANE DERIVATIVE, PRODRUG THEREOF AND SALT THEREOF, AND THERAPEUTIC AGENT CONTAINING THE SAME FOR DIABETES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318874-A1 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes SLC5A1, GPR119, SLC5A2 ABCB1 258/4885MAPT 4638/4885TDP1 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.